|
Fiscal Period: January
|
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
Capitalization1 |
26 022 | 18 088 | 25 194 | 28 609 | 30 751 | 17 519 | - | - |
Enterprise Value (EV)1 |
29 216 | 21 975 | 28 414 | 31 475 | 37 204 | 23 539 | 23 441 | 22 937 |
P/E ratio |
21,1x | 28,1x | 26,1x | 23,0x | 18,6x | 14,2x | 10,0x | 8,85x |
Yield |
1,43% | 2,15% | 1,63% | 1,56% | 1,58% | 2,53% | 2,73% | 3,29% |
Capitalization / Revenue |
2,04x | 1,29x | 1,74x | 1,97x | 1,97x | 0,92x | 0,88x | 0,85x |
EV / Revenue |
2,29x | 1,57x | 1,97x | 2,17x | 2,38x | 1,24x | 1,18x | 1,12x |
EV / EBITDA |
12,5x | 9,12x | 11,3x | 11,6x | 13,5x | 9,01x | 7,95x | 7,26x |
Price to Book |
3,12x | 2,24x | 2,73x | 2,52x | 2,58x | 1,81x | 1,81x | 1,62x |
Nbr of stocks (in thousands) |
153 352 | 151 060 | 152 012 | 160 223 | 163 033 | 150 965 | - | - |
Reference price (USD) |
170 | 120 | 166 | 179 | 189 | 116 | 116 | 116 |
Announcement Date |
01/24/2018 | 01/22/2019 | 01/29/2020 | 01/28/2021 | 02/01/2022 | - | - | - |
1 USD in Million |
|
|
Income Statement Evolution (Annual data) |
|
Fiscal Period: January
|
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
Net sales1 |
12 747 | 13 982 | 14 442 | 14 535 | 15 617 | 19 041 | 19 859 | 20 546 |
EBITDA1 |
2 343 | 2 409 | 2 504 | 2 704 | 2 754 | 2 613 | 2 950 | 3 159 |
Operating profit (EBIT)1 |
1 882 | 1 903 | 1 944 | 2 126 | 2 177 | 2 216 | 2 549 | 2 706 |
Operating Margin |
14,8% | 13,6% | 13,5% | 14,6% | 13,9% | 11,6% | 12,8% | 13,2% |
Pre-Tax Profit (EBT)1 |
1 526 | 1 073 | 1 130 | 1 267 | 1 641 | 1 323 | 2 009 | 2 299 |
Net income1 |
1 226 | 645 | 956 | 1 210 | 1 689 | 1 299 | 1 757 | 1 965 |
Net margin |
9,62% | 4,62% | 6,62% | 8,33% | 10,8% | 6,82% | 8,85% | 9,56% |
EPS2 |
8,04 | 4,26 | 6,35 | 7,77 | 10,2 | 8,18 | 11,6 | 13,1 |
Dividend per Share2 |
2,42 | 2,58 | 2,70 | 2,78 | 2,98 | 2,93 | 3,16 | 3,82 |
Announcement Date |
01/24/2018 | 01/22/2019 | 01/29/2020 | 01/28/2021 | 02/01/2022 | - | - | - |
1 USD in Million 2 USD |
|
|
Income Statement Evolution (Quarterly data) |
|
Fiscal Period: January
|
2019 Q4 |
2020 Q1 |
2020 Q2 |
2020 Q3 |
2020 Q4 |
2021 Q1 |
2021 Q2 |
2021 Q3 |
2021 Q4 |
2022 Q1 |
2022 Q2 |
2022 Q3 |
2022 Q4 |
2023 Q1 |
2023 Q2 |
Net sales1 |
3 714 | 3 129 | 3 147 | 3 850 | 4 408 | 4 197 | 4 301 | 4 263 | 4 068 | 4 448 | 4 773 | 4 904 | 4 900 | 4 746 | 5 127 |
EBITDA1 |
647 | 455 | 547 | 826 | 876 | 881 | 810 | 666 | 513 | 657 | 647 | 718 | 706 | 727 | 832 |
Operating profit (EBIT)1 |
507 | 314 | 403 | 680 | 729 | 737 | 668 | 522 | 366 | 513 | 537 | 608 | 602 | 606 | 683 |
Operating Margin |
13,6% | 10,0% | 12,8% | 17,7% | 16,5% | 17,6% | 15,5% | 12,2% | 9,00% | 11,5% | 11,3% | 12,4% | 12,3% | 12,8% | 13,3% |
Pre-Tax Profit (EBT)1 |
237 | 146 | 111 | 470 | 540 | 605 | 528 | 404 | 161 | 179 | 343 | 430 | 400 | 495 | 543 |
Net income1 |
199 | 133 | 234 | 386 | 458 | 478 | 455 | 414 | 328 | 175 | 300 | 400 | 404 | 417 | 456 |
Net margin |
5,36% | 4,26% | 7,43% | 10,0% | 10,4% | 11,4% | 10,6% | 9,72% | 8,07% | 3,94% | 6,29% | 8,16% | 8,25% | 8,79% | 8,89% |
EPS2 |
1,32 | 0,88 | 1,52 | 2,44 | 2,88 | 2,98 | 2,81 | 2,56 | 1,99 | 1,06 | 2,02 | 2,62 | 2,59 | 2,75 | 3,06 |
Dividend per Share |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Announcement Date |
01/29/2020 | 04/30/2020 | 07/30/2020 | 10/27/2020 | 01/28/2021 | 04/28/2021 | 07/27/2021 | 10/28/2021 | 02/01/2022 | 04/28/2022 | - | - | - | - | - |
1 USD in Million 2 USD |
|
|
|
Fiscal Period: January
|
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
Net Debt1 |
3 194 | 3 887 | 3 219 | 2 866 | 6 452 | 6 020 | 5 922 | 5 418 |
Net Cash position1 |
- | - | - | - | - | - | - | - |
Leverage (Debt / EBITDA) |
1,36x | 1,61x | 1,29x | 1,06x | 2,34x | 2,30x | 2,01x | 1,71x |
Free Cash Flow1 |
976 | 769 | 1 081 | 1 674 | 144 | 1 301 | 1 888 | 1 947 |
ROE (Net Profit / Equities) |
16,7% | 7,98% | 11,3% | 12,0% | 15,3% | 13,8% | 17,5% | 17,1% |
Shareholders' equity1 |
7 332 | 8 089 | 8 486 | 10 098 | 11 065 | 9 435 | 10 054 | 11 501 |
ROA (Net Profit / Asset) |
7,06% | 3,35% | 4,78% | 5,48% | 6,68% | 5,26% | 6,13% | - |
Assets1 |
17 357 | 19 253 | 20 002 | 22 081 | 25 288 | 24 688 | 28 647 | - |
Book Value Per Share2 |
54,4 | 53,4 | 60,7 | 71,0 | 73,0 | 64,3 | 64,1 | 71,4 |
Cash Flow per Share2 |
9,31 | 8,31 | 10,0 | 13,0 | 4,02 | 12,4 | 17,5 | 17,3 |
Capex1 |
442 | 492 | 425 | 348 | 519 | 560 | 613 | 596 |
Capex / Sales |
3,47% | 3,52% | 2,94% | 2,39% | 3,32% | 2,94% | 3,09% | 2,90% |
Announcement Date |
01/24/2018 | 01/22/2019 | 01/29/2020 | 01/28/2021 | 02/01/2022 | - | - | - |
1 USD in Million 2 USD |
|
| |
|
|
Wall St closes higher as vaccine update feeds optimism |
Capitalization (USD) |
17 519 445 427 |
Net sales (USD) |
15 617 200 000 |
Number of employees |
71 300 |
Sales / Employee (USD) |
219 035 |
Free-Float |
85,0% |
Free-Float capitalization (USD) |
14 898 451 268 |
Avg. Exchange 20 sessions (USD) |
308 303 113 |
Average Daily Capital Traded |
1,76% |
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
|